Back

Early treatment outcome prediction in metastatic castration-resistant prostate cancer utilizing 3-month tumor growth rate (g-rate) based machine learning model

2026-03-03 oncology Title + abstract only
View on medRxiv
Show abstract

BackgroundOnce the treatment starts, early prediction of treatment benefit and its correlation with overall survival (OS) remains challenging in metastatic castration-resistant prostate cancer (mCRPC). Existing prognostic models require long-term follow-up, limiting their ability to inform timely treatment decisions. To address this gap, we evaluated tumor growth rate (g-rate)-based survival models across multiple treatment lines to assess their ability to predict OS and support early clinical d...

Predicted journal destinations